Conjunctival Malt Lymphoma: A Case Report


Tuna S., Karacetin D., Basaran M., Agaoglu F., Dogan O., BÜYÜKBABANİ N.

ISTANBUL MEDICAL JOURNAL, vol.10, no.4, pp.198-201, 2009 (ESCI) identifier

  • Publication Type: Article / Article
  • Volume: 10 Issue: 4
  • Publication Date: 2009
  • Journal Name: ISTANBUL MEDICAL JOURNAL
  • Journal Indexes: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Page Numbers: pp.198-201
  • Keywords: MALT (Mucosa Associated Lymphoid Tissue) lymphoma, Chemotherapy, Radiotherapy, HELICOBACTER-PYLORI INFECTION, B-CELL LYMPHOMA, BORRELIA-BURGDORFERI, CHLAMYDIA-PSITTACI, MARGINAL ZONE, THERAPY
  • Istanbul University Affiliated: Yes

Abstract

Whilst the etiology of the MALT (Mucosa Associate Lymphoid Tissue) lymphoma is not perfectly clarified, the blamed mechanism is a mature B-cell lymphoproliferative processes. This process is considered to have developed in connection with chronic antigenic stimulation which belongs to the extranodal marginal zone B-cell non-hodgkin indolent lymphoma class. A majority of the MALT lymphoma appear in the gastrointestinal system yet they may appear in tissue and organs like orbita, conjunctiva, lacrimal gland, bladder, lung, dura, thyroid, breast, and skin. Generally they have slow course and favorable prognoses. Chemotherapy and radiotherapy treatment options might be used. In this article, we are reporting 43 year old, female conjunctival MALT lymphoma demonstrative case with clinic and pathological specifications.